Mark Cuban intros online pharmacy offering affordable genericsThe pharmacy is expected to offer more than 100 generic drugs at an affordable price. Alembic receives tentative nod for 2 genericsAlembic has received tentative approval from the Food and Drug Administration for dronedarone tablets and vortioxetine tablets. FDA green-lights Alembic’s generic Comtan Entacapone tablets have a market value of roughly $10.5 million for the 12 months ending September 2021. Lupin obtains FDA approval, tentative OK for 2 generics The Food and Drug Administration approved Lupin’s sevelamer carbonate for oral suspension and gave tentative approval for azilsartan medoxomil tablets. Par launches generic Cuvposa The product is indicated to reduce chronic severe drooling in children ages 3 to 16 years old with neurologic conditions that cause abnormal drooling. Amneal to acquire Saol Therapeutics’ Baclofen franchise The acquisition expands Amneal’s neurology presence into spasticity. U.S. Court of Appeals for the Federal Circuit upholds validity of Novartis’ Gilenya dosage regimen patent Novartis said it expects no generic versions of Gilenya in the U.S. market for at least the next two years. Alembic given FDA OK for generic Doryx Doxycycline hyclate delayed-release tablets have a market value of roughly $10 million for the 12 months ending September 2021, according to IQVIA. Teva debuts generic Narcan Teva’s generic Narcan provides a treatment for opioid emergencies. Camber intros generic Adderall XR The medication is indicated for the treatment of attention deficit hyperactivity disorder. First Previous 87 88 89 90 91 Next Last